Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by gudisgoodon Apr 04, 2021 1:33am
143 Views
Post# 32934686

RE:RE:RE:Annual Report is now available ...

RE:RE:RE:Annual Report is now available ...
Chianchin wrote: Progress..........????? Share price for $10.70 to $5.50?  Six Years latter...


I mean progress if you look at the underlying business. In fact, the business set-up is completely different now when compared to, say, two years ago. Still lots of cash, but the company just produced $30M of net income last year, has a strong platform for product acquisitions, is in the approval or launch phase for many products, and the integration is still a year away from being completed.

In my opinion, the business is very likely to make more money in 2021 than it did in 2020, perhaps significantly so, unless something horrible happens in the overall market. Brazil is the biggest market for Knight and it had quite a lousy year (to say the least!) but the business is doing well despite of that.
<< Previous
Bullboard Posts
Next >>